What is Gilbert syndrome and how is it managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gilbert Syndrome: Definition and Management

Gilbert syndrome is a benign hereditary condition affecting 5–10% of the population that requires no treatment beyond patient reassurance. 1

What is Gilbert Syndrome?

Gilbert syndrome is an autosomal dominant hereditary disorder characterized by intermittent unconjugated (indirect) hyperbilirubinemia in the absence of hepatocellular disease or hemolysis. 1, 2 The condition results from reduced activity of the enzyme uridine diphosphate-glucuronosyltransferase (UGT1A1) to approximately 20–30% of normal levels, impairing the liver's ability to conjugate bilirubin with glucuronic acid. 1, 2

Key Clinical Features

  • Mild unconjugated hyperbilirubinemia: Total bilirubin typically remains below 4–5 mg/dL, though levels can occasionally exceed 6 mg/dL. 1
  • Intermittent jaundice: Bilirubin levels fluctuate and may increase during fasting, stress, illness, or physical exertion. 2
  • Normal liver function: All liver enzymes (ALT, AST, alkaline phosphatase, GGT) remain within normal ranges. 1, 2
  • No hemolysis: Complete blood count shows no evidence of red blood cell destruction. 1, 2

The most common genetic variant is homozygous polymorphism A(TA)7TAA in the UGT1A1 gene promoter, designated as UGT1A1*28. 3

Diagnostic Approach

The diagnosis is established by demonstrating that unconjugated bilirubin comprises more than 70–80% of total bilirubin (or conversely, that conjugated bilirubin is less than 20–30% of total bilirubin) in the setting of normal liver enzymes and absence of hemolysis. 4, 1

Step-by-Step Diagnostic Algorithm

  1. Measure total and direct (conjugated) bilirubin levels and calculate the percentage of conjugated bilirubin. 1, 2

  2. Verify the conjugated fraction is <20–30% of total bilirubin; if this criterion is met and hemolysis is absent, Gilbert syndrome can be presumed. 1, 2

  3. Confirm normal hepatocellular function by documenting that ALT, AST, and alkaline phosphatase are within reference ranges. 1, 2

  4. Systematically exclude hemolysis using complete blood count, reticulocyte count, peripheral smear, haptoglobin, and LDH measurements. 1

  5. Avoid routine abdominal ultrasound because imaging adds no diagnostic value when unconjugated hyperbilirubinemia is present with normal liver enzymes; reserve ultrasound only for cases where conjugated hyperbilirubinemia or biliary obstruction is suspected. 1

Important Diagnostic Pitfall

Gilbert syndrome can be mistaken for drug-induced liver injury (DILI), leading to unnecessary drug interruption or discontinuation. 1 When hyperbilirubinemia is due to DILI rather than Gilbert syndrome, the fraction of direct bilirubin is usually greater than 35% (versus less than 20–30% in Gilbert syndrome). 1 This distinction is critical to avoid inappropriate medication changes.

Management

No specific pharmacologic therapy is required; management consists entirely of patient education and reassurance that the condition is benign and does not affect life expectancy. 1, 2

Patient Counseling Points

  • Reassure patients fully that Gilbert syndrome is a benign condition requiring no treatment. 4
  • Inform healthcare providers about the diagnosis to prevent unnecessary testing during episodes of jaundice. 2
  • Explain that bilirubin levels may temporarily increase during fasting, illness, stress, or physical exertion, but these fluctuations are harmless. 2

Special Considerations in Clinical Trials

In oncology clinical trials, eligibility and on-study monitoring should focus on elevations of direct (conjugated) bilirubin rather than total bilirubin when participants have Gilbert syndrome. 1 This approach prevents inappropriate exclusion of patients or misinterpretation of treatment-related toxicity. 5

Potential Protective Effects

Emerging research suggests that mild unconjugated hyperbilirubinemia in Gilbert syndrome may confer antioxidant benefits, potentially reducing the prevalence of cardiovascular disease, type 2 diabetes, certain cancers, and all-cause mortality. 6, 7 However, these observations do not change clinical management, as the condition remains benign and requires no intervention.

References

Guideline

Gilbert Syndrome: Diagnosis and Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Gilbert Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gilbert syndrome.

European journal of pediatrics, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Gilbert's syndrome--myths and reality].

Casopis lekaru ceskych, 2004

Research

[Gilbert's syndrome: hyperbilirubinemia enemy or friend].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021

Related Questions

What is the management and treatment of Gilbert's syndrome?
What is Gilbert syndrome (a genetic disorder characterized by mildly elevated levels of unconjugated bilirubin)?
What is the best management approach for a 50-year-old male with Gilbert's syndrome, hypotestosteronism (low testosterone), supraventricular ectopy, heterozygous Methylenetetrahydrofolate Reductase (MTHFR) mutation, Postural Orthostatic Tachycardia Syndrome (POTS), and symptoms of fatigue?
What is Gilbert's disease (Gilbert's syndrome)?
What is the recommended treatment for a patient with Gilbert syndrome?
How should I evaluate and manage suspected plantar neuropathy in an adult with obesity (BMI 38) and poorly controlled type 2 diabetes (daytime glucose up to 150 mg/dL, nighttime 110–120 mg/dL)?
How should I manage a female patient with five days of persistent diarrhea and vomiting, no dehydration, and no response to current medication?
Is it appropriate to initiate lisinopril (ACE inhibitor) in a patient with acute kidney injury and serum creatinine of 1.98 mg/dL who is receiving fluid resuscitation and has blood pressure 183/92 mmHg?
For an adult with obesity (body mass index ≥ 30 kg/m² or ≥ 27 kg/m² with weight‑related comorbidities) and no type 2 diabetes, how should retatrutide be initiated, titrated, monitored, and what are its efficacy and safety profile?
What should I do about my elevated plasma vitamin B6 (pyridoxine) level?
Does NHS Improvement (NHSI) provide a definition for central line-associated bloodstream infection (CLABSI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.